The media believe that the vaccines in question are two mRNA-derived vaccine candidates developed by Moderna (MRNA) and by the Pfizer (PFE)/BioNTech (BNTX) group. The reason for the prediction is that two vaccinations are required for each of the two vaccines separated by two weeks, which applies to both Moderna’s and Pfizer’s vaccines.
The CDC mentioned vaccines are to be stored under negative temperatures. We reported on September 1st, under Impacting News, that executives from Moderna and the Pfizer/BioNTech group have told the CDC Advisory Committee on Immunization Practice that their vaccines need to be stored at a negative 4 degrees Fahrenheit for Moderna’s vaccine mRNA-1273, and a negative 94 degrees Fahrenheit for BioNTech/Pfizer vaccines BN1162b2 and BNT12b2.
So we know now at least which vaccines the CDC will start with.
Prohost Observations
As we have mentioned several times before, vaccinating the whole world would need several vaccines from several firms. In fact, various countries are already ordering their vaccines from different vaccine developers. So, this news could be pretty good for Moderna and Pfizer’s group as well as for the vulnerable populations, healthcare workers and most likely many other groups of people. It is not, however, bad news for the other vaccine developer firms that demonstrated safety and efficacy but still have yet to reach Phase 3 trials.
To read more about these firms and COVID-19 please use the search engine at our website.
The U.S. CDC Tells the 50 States to Prepare for COVID-19 Vaccines by the End of October
CDC Is Asking States to Prepare for COVID-19 Vaccines
The U.S. Center of Disease Control and Prevention (CDC) has asked the 50 states’ public health officials to be ready to distribute potential COVID-19 vaccines to high-risk people, healthcare workers and others as soon as late October, as showed in a document yesterday.
The New York Times (NYT) has also reported today that the CDC has contacted the officials in the 50 states.
Dr. Anthony Fauci, the top infectious disease expert, has also confirmed the news to MSNBC. He stated that with the patient enrollment rate for COVID-19 vaccine trials underway there could be enough clinical data to know by November or December that a vaccine is safe and effective.
Other Articles